US Stock MarketDetailed Quotes

Enanta Pharmaceuticals (ENTA)

Watchlist
  • 13.410
  • -0.400-2.90%
Close May 15 16:00 ET
  • 13.410
  • 0.0000.00%
Post 16:10 ET
389.94MMarket Cap-5.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enanta Pharmaceuticals (ENTA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Mar 31, 2026
(Q1)Dec 31, 2025
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
Total revenue
14.96%17.16M
9.76%18.62M
-3.42%65.32M
3.55%15.13M
1.91%18.31M
-12.48%14.93M
-5.80%16.96M
-14.61%67.64M
-22.84%14.61M
-4.88%17.97M
Operating revenue
14.96%17.16M
9.76%18.62M
-3.42%65.32M
3.55%15.13M
1.91%18.31M
-12.48%14.93M
-5.80%16.96M
-14.61%67.64M
-22.84%14.61M
-4.88%17.97M
Cost of revenue
Gross profit
Operating expense
-26.47%29.01M
-26.26%29.87M
-20.42%150.67M
-24.63%33.51M
-11.74%37.21M
-20.81%39.45M
-23.42%40.5M
-12.52%189.33M
-11.01%44.46M
-24.19%42.16M
Selling and administrative expenses
-15.98%9.57M
-29.87%9.01M
-24.06%43.93M
-29.09%9.7M
-25.47%10M
-20.00%11.39M
-22.23%12.85M
9.38%57.85M
-0.81%13.68M
6.31%13.41M
-General and administrative expense
-15.98%9.57M
-29.87%9.01M
-24.06%43.93M
-29.09%9.7M
-25.47%10M
-20.00%11.39M
-22.23%12.85M
9.38%57.85M
-0.81%13.68M
6.31%13.41M
Research and development costs
-30.72%19.44M
-24.58%20.86M
-18.81%106.74M
-22.64%23.81M
-5.33%27.21M
-21.13%28.07M
-23.96%27.66M
-19.60%131.48M
-14.90%30.78M
-33.14%28.74M
Operating profit
51.68%-11.85M
52.20%-11.25M
29.86%-85.35M
38.41%-18.39M
21.88%-18.89M
25.14%-24.53M
32.51%-23.54M
11.31%-121.69M
3.79%-29.85M
34.12%-24.19M
Net non-operating interest income expense
-313.15%-1.23M
-178.97%-661K
-54.02%1.76M
-153.95%-321K
-41.08%667K
-53.61%578K
-2.33%837K
-38.35%3.83M
-60.67%595K
-39.43%1.13M
Non-operating interest income
-9.08%2.08M
-13.47%2.42M
-36.07%9.44M
-34.95%2.07M
-34.47%2.29M
-39.83%2.29M
-34.88%2.8M
30.02%14.77M
-31.90%3.18M
-9.80%3.49M
Non-operating interest expense
93.47%3.32M
57.14%3.08M
-29.79%7.68M
-7.52%2.39M
-31.30%1.62M
-33.13%1.71M
-42.98%1.96M
112.51%10.94M
-18.09%2.58M
17.93%2.36M
Other net income (expense)
-46.58%39K
73K
Gain on sale of security
----
----
-46.58%39K
----
----
----
----
--73K
----
----
Income before tax
45.37%-13.08M
47.53%-11.91M
29.07%-83.55M
36.04%-18.67M
20.94%-18.23M
24.02%-23.95M
33.27%-22.71M
10.08%-117.79M
1.12%-29.19M
33.84%-23.05M
Income tax
100.54%7K
105.77%24K
4.76%-1.66M
108.82%32K
107.34%29K
-259.50%-1.31M
33.12%-416K
-161.79%-1.74M
74.26%-363K
-109.36%-395K
Net income
42.19%-13.09M
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
Net income continuous Operations
42.19%-13.09M
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
Minority interest income
Net income attributable to the parent company
42.19%-13.09M
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
42.19%-13.09M
46.44%-11.94M
29.43%-81.89M
35.12%-18.7M
19.43%-18.26M
27.32%-22.64M
33.28%-22.29M
13.28%-116.05M
-2.55%-28.82M
42.00%-22.66M
Basic earnings per share
57.55%-0.45
60.00%-0.42
29.93%-3.84
36.03%-0.87
20.56%-0.85
27.89%-1.06
33.54%-1.05
14.11%-5.48
-2.26%-1.36
42.47%-1.07
Diluted earnings per share
57.55%-0.45
60.00%-0.42
29.93%-3.84
36.03%-0.87
20.56%-0.85
27.89%-1.06
33.54%-1.05
14.11%-5.48
-2.26%-1.36
42.47%-1.07
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Mar 31, 2026(Q1)Dec 31, 2025(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024
Total revenue 14.96%17.16M9.76%18.62M-3.42%65.32M3.55%15.13M1.91%18.31M-12.48%14.93M-5.80%16.96M-14.61%67.64M-22.84%14.61M-4.88%17.97M
Operating revenue 14.96%17.16M9.76%18.62M-3.42%65.32M3.55%15.13M1.91%18.31M-12.48%14.93M-5.80%16.96M-14.61%67.64M-22.84%14.61M-4.88%17.97M
Cost of revenue
Gross profit
Operating expense -26.47%29.01M-26.26%29.87M-20.42%150.67M-24.63%33.51M-11.74%37.21M-20.81%39.45M-23.42%40.5M-12.52%189.33M-11.01%44.46M-24.19%42.16M
Selling and administrative expenses -15.98%9.57M-29.87%9.01M-24.06%43.93M-29.09%9.7M-25.47%10M-20.00%11.39M-22.23%12.85M9.38%57.85M-0.81%13.68M6.31%13.41M
-General and administrative expense -15.98%9.57M-29.87%9.01M-24.06%43.93M-29.09%9.7M-25.47%10M-20.00%11.39M-22.23%12.85M9.38%57.85M-0.81%13.68M6.31%13.41M
Research and development costs -30.72%19.44M-24.58%20.86M-18.81%106.74M-22.64%23.81M-5.33%27.21M-21.13%28.07M-23.96%27.66M-19.60%131.48M-14.90%30.78M-33.14%28.74M
Operating profit 51.68%-11.85M52.20%-11.25M29.86%-85.35M38.41%-18.39M21.88%-18.89M25.14%-24.53M32.51%-23.54M11.31%-121.69M3.79%-29.85M34.12%-24.19M
Net non-operating interest income expense -313.15%-1.23M-178.97%-661K-54.02%1.76M-153.95%-321K-41.08%667K-53.61%578K-2.33%837K-38.35%3.83M-60.67%595K-39.43%1.13M
Non-operating interest income -9.08%2.08M-13.47%2.42M-36.07%9.44M-34.95%2.07M-34.47%2.29M-39.83%2.29M-34.88%2.8M30.02%14.77M-31.90%3.18M-9.80%3.49M
Non-operating interest expense 93.47%3.32M57.14%3.08M-29.79%7.68M-7.52%2.39M-31.30%1.62M-33.13%1.71M-42.98%1.96M112.51%10.94M-18.09%2.58M17.93%2.36M
Other net income (expense) -46.58%39K73K
Gain on sale of security ---------46.58%39K------------------73K--------
Income before tax 45.37%-13.08M47.53%-11.91M29.07%-83.55M36.04%-18.67M20.94%-18.23M24.02%-23.95M33.27%-22.71M10.08%-117.79M1.12%-29.19M33.84%-23.05M
Income tax 100.54%7K105.77%24K4.76%-1.66M108.82%32K107.34%29K-259.50%-1.31M33.12%-416K-161.79%-1.74M74.26%-363K-109.36%-395K
Net income 42.19%-13.09M46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M
Net income continuous Operations 42.19%-13.09M46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M
Minority interest income
Net income attributable to the parent company 42.19%-13.09M46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 42.19%-13.09M46.44%-11.94M29.43%-81.89M35.12%-18.7M19.43%-18.26M27.32%-22.64M33.28%-22.29M13.28%-116.05M-2.55%-28.82M42.00%-22.66M
Basic earnings per share 57.55%-0.4560.00%-0.4229.93%-3.8436.03%-0.8720.56%-0.8527.89%-1.0633.54%-1.0514.11%-5.48-2.26%-1.3642.47%-1.07
Diluted earnings per share 57.55%-0.4560.00%-0.4229.93%-3.8436.03%-0.8720.56%-0.8527.89%-1.0633.54%-1.0514.11%-5.48-2.26%-1.3642.47%-1.07
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -